Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2

Clinical trial NCT00281658 · COMPLETED

Trial details

NCT number: NCT00281658
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2006-01-02
Primary completion: 2010-06-18
Enrollment: 444

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.